Search Results
The default setting for search results displays All Content. If you prefer to see recent content only, please adjust the date filter.
Filter your results:
Types
Topics
32 Results Found
FDA issues Class I recall for Olympus endoscope needles
The Food and Drug Administration has identified a Class I recall of certain Olympus ViziShot 2 FLEX Needles due to a possible patient safety issue caused by a potentially deformed a-traumatic tip.
AHA Statement of Record for Senate Special Committee on Aging Hearing on Pharmaceutical and Medical Supply Chains
The American Hospital Association statement for the record to the Senate Special Committee on Aging hearing “Bad Medicine: Closing Loopholes that Kill American Patients.”
AHA Urges Administration to Grant Exceptions for Current and Proposed Tariffs for Medications and Medical Supplies
The AHA late yesterday told the administration that its current and proposed tariffs on Canada, Mexico and China may jeopardize the availability of vital medications and essential health care devices.
Tariff Implications for American Health Care
A series of tariffs recently implemented could have significant implications for health care.
Planning for Resiliency in the IV Fluid Supply Chain
In this conversation, Mark Taylor, M.D., surgical director for surgical operations at Cleveland Clinic, discusses the health system's ongoing IV fluid conservation strategies and the importance of constant and targeted communication during supply chain shortages.
AHA Urges Administration to Grant Exceptions for Tariffs for Medications and Medical Supplies
The AHA asks President Trump to consider granting exceptions to the current and proposed tariffs for medical devices and pharmaceuticals made in Mexico, Canada and China that are essential to the provision of safe, effective care in America's hospitals, clinics, and other settings.
AHA Comments on Commerce Department Investigation of Pharmaceutical Imports
AHA comments on the Department of Commerce’s request for public comment on its Section 232 national security investigation on pharmaceutical and pharmaceutical ingredient imports.
AHA Responds to Commerce Department Investigation of Critical Minerals
AHA comments on the Department of Commerce’s request for public comment on its Section 232 national security investigation on processed critical minerals and derivative products.
Trump Administration Unveils New Tariff Plan
The White House April 2 issued an executive order implementing a comprehensive new tariff plan.
Chair File: Leadership Dialogue — Tariffs and Health Care with Brian Pomper and Akin Demehin
In this Leadership Dialogue, I am joined by Brian Pomper, a partner specializing in international trade policy at Akin Gump Strauss Hauer & Feld, and Akin Demehin, vice president of quality and safety policy at the AHA. We discuss tariffs and their potential implications on the health care supply chain.